MedPath

Effect of Acupressure-Ice Message on Primary Dysmenorrhea

Not Applicable
Not yet recruiting
Conditions
Primary Dysmenorrhea
Interventions
Other: pelvic rocking exercises
Other: acupressure ice massage
Registration Number
NCT06578013
Lead Sponsor
Cairo University
Brief Summary

This study will be conducted to determine the effect of acupressure ice massage on primary dysmenorrhea.

Detailed Description

Dysmenorrhea is considered the most common gynecological complaint by young women and affects approximately 60-80% of the female population. Around 8-18% of that population report intense discomfort, causing absenteeism in several daily activities while suffering pain.

Analgesics are considered the first line of treatment, but they are known for their undesirable effects such as renal, cardiovascular and gastrointestinal complications that can negatively affect patients' health. Physical therapy has alternative techniques that assist in analgesia in a practical and effective way; among them is acupressure and cryo therapy.

The effect of application of ice on the skin has a direct action on neurons and pain receptors, lowering the speed and the number of nerve impulses. This effect is due to its action on the gate control of pain mechanism, leading to the release of endorphins and enkephalins that are pain-relieving substances.

It was proved from previous studies that using ice massage on L14 or SP6 points reduce pain intensity in females suffering from PD. So, further studies are needed to investigate the effect of acupressure ice massage not only on pain intensity but also on other symptoms severity and quality of life of females suffering from PD. Therefore, this study will be conducted for this issue which will be of valuable benefits for medical service organization and increase body of knowledge of physical therapy in scientific field.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Fifty adolescents' females who are clinically diagnosed as primary dysmenorrhea.
  • Their ages will be ranged from 17-25 years old.
  • Their BMI will be less than 30 kg/m².
  • All of them are virgin.
  • Their pain level will be more than 3 on visual analogue scale.
  • Having mild to moderate score on Menstrual Distress questionnaire (MDQ) ( ≥ 50).
  • Having regular menstruation for the last 6 months (every 28-30 days with no intermittent bleeding).
Exclusion Criteria
  • Systematic chronic diseases or any pelvic inflammatory diseases.
  • Secondary dysmenorrhea.
  • Menstrual irregularity.
  • Nerve damage resulting in loss of feeling.
  • Swelling, scar or skin infection.
  • Diabetic patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
pelvic rocking exercisespelvic rocking exercisesIt will include 25 participants suffering from primary dysmenorrhea, who will perform pelvic rocking exercises only, 15 minutes/session, 3 times /week, for 3 successive menstrual cycles.
acupressure ice massage + pelvic rocking exercisespelvic rocking exercisesIt will include 25 participants suffering from primary dysmenorrhea who will receive acupressure ice massage on SP6 and L14 acupoints, 10 minutes on each point for 20 minutes each session, 5 sessions per cycle (through the 5 days before menstruation) for 3 consecutive menstrual cycles, in addition to pelvic rocking exercises, 15 minute/session, 3 times /week, for 3 successive menstrual cycles.
acupressure ice massage + pelvic rocking exercisesacupressure ice massageIt will include 25 participants suffering from primary dysmenorrhea who will receive acupressure ice massage on SP6 and L14 acupoints, 10 minutes on each point for 20 minutes each session, 5 sessions per cycle (through the 5 days before menstruation) for 3 consecutive menstrual cycles, in addition to pelvic rocking exercises, 15 minute/session, 3 times /week, for 3 successive menstrual cycles.
Primary Outcome Measures
NameTimeMethod
Pain intensity assessment3 months

It will be assessed for each participant in both groups (A \& B) before and after treatment, using the visual analogue scale (VAS). The VAS is usually presented as a 10 cm horizontal line on which the participants' pain intensity is represented by a point between the extremes of " no pain at all " and " worst pain imaginable ". It's simplicity, reliability and validity as well as its ratio scale properties make the VAS the optional tool for describing pain intensity.

Assessment of pain pressure threshold3 months

A pressure algometer will be used to measure pain pressure thresholds (PPTs) for all participants in both groups before and after treatment, coinciding with peak menstrual pain on the first day of menstruation. Six specific points around the umbilicus and lower back will be assessed, with each point measured twice using a 1-cm² probe applied at 30kPa/s. The areas will be cleaned with alcohol before testing. Two points will be measured 4cm bilaterally from the umbilicus, two more 4cm below these, one 4cm below the umbilicus, and one in the lumbar region at S2-S4. The mean values of these points will be used for PPT data analysis.

Menstrual distress questionnaire (MDQ)3 months

It will be used pre and post- treatment to assess the severity of symptoms of primary dysmenorrhea for all participants in both groups (A \& B). The MDQ consists of symptoms or feelings associated with menstruation. The total number of items is 47. It is a 5 point rating scale from 0-4. For each items, there is 5 options i.e. No, mild, moderate, severe and very severe. An option of (very severe) has a score of 4, (severe) has a score of 3, (moderate) has a score of 2, (mild) has a score of 1, (No) has a score of 0. It includes seven sub-scales as (pain, water retention, autonomic reactions, negative affect, impaired concentration, mood and behavioral changes, arousal control). Overall Score was interpreted as follows :\< 50 - mild , 50 to 70 - moderate and \>70 severe.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Doaa Ashraf Abd El-Ghany

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath